CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Terlipressin given as continuous intravenous infusion is the more suitable schedule for the treatment of type 1 hepatorenal syndrome (HRS) in patients with cirrhosis: results of a controlled clinical study
Authors
Paolo Angeli
G. P. Benetti
+9 more
A. Callegaro
M. Cavallin
Silvano Fasolato
A. Galioto
Angelo Gatta
Giulio Maresio
Elena Mazza
Antonietta Sticca
A. Trotta
Publication date
1 January 2008
Publisher
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Archivio istituzionale della ricerca - Università di Padova
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:www.research.unipd.it:1157...
Last time updated on 12/11/2016